Epidemiology of the Nasal Flora at the Reference Center for Cystic Fibrosis of Queen Fabiola Children's University Hospital.
NCT03911258 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2019-04-16
Summary
Cystic fibrosis (CF) is the most common autosomal recessive inherited genetic disorder in North America, Australia and Europe.
CF is due to cystic fibrosis transmembrane conductance regulator gene mutation (CFTR) coding for a chloride channel located at the apical membrane of epithelial cells. The most common mutation is the deletion of the amino acid phenylalanine at the codon 508 (ΔF508) affecting 70% of the patients.
The CFTR channel participates in the regulation of the volume and composition of exocrine secretions. At the level of the lungs, this results in a thickening of the mucus with a dysfunction of the mucociliary clearance promoting colonization of pathogenic microorganisms. Patients with cystic fibrosis therefore have a natural susceptibility to develop acute and then chronic respiratory infections, gradually leading to irreversible respiratory tract lesions called bronchiectasis. Different germs such as Haemophilus influenzae and Staphylococcus aureus colonize the airways early in life. The progression of the disease causes furthermore a colonization by opportunistic germs such as Pseudomonas aeruginosa and Burkholderia cepacia, which are associated with higher mortality.
Pulmonary exacerbation is a common complication of CF requiring administration of antibiotics. The choice of these antibiotics depends on the germs that the patient carries in his respiratory tract.
The type of sampling and the conditions under which they are taken are therefore very important. Sputum and oropharyngeal smear are used in adolescents and children respectively to collect respiratory secretions in clinical routine. The recent literature describes induced sputum, obtained after a physiotherapy session and a hypertonic serum aerosol, as superior to the oropharyngeal smear alone and equivalent to bronchoalveolar lavage for the evaluation of the microbiological profile of patients who cannot expectorate. However, this technique takes time and requires the presence of a physiotherapist.
Bronchoalveolar lavage is reserved for complex cases that do not respond to standard treatments.
Finally, the nasal flora appears to be involved in the colonization of the lower respiratory tract. Sinuses are described as reservoirs of germs that can induce a recolonization of the lungs despite eradication of the germ (for example after a pulmonary transplantation) .
To our knowledge, no study has investigated the involvement of nasal flora in the clinical course of children with CF.
Conditions
Interventions
- PROCEDURE
-
nasopharyngeal swab versus nasal wash
The type of procedure will be determine according to patient collaboration
Sponsors & Collaborators
-
Queen Fabiola Children's University Hospital
lead OTHER
Principal Investigators
-
Jean-Christophe Beghin, MD · Queen Fabiola Children's University Hospital
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-06
- Primary Completion
- 2020-04-30
- Completion
- 2020-04-30
Countries
- Belgium
Study Locations
More Related Trials
-
Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria
NCT05686837 ·Status: ENROLLING_BY_INVITATION
-
Functional Analysis by Dynamic Imaging of the Respiratory Epithelium in Infants With Cystic Fibrosis
NCT01605565 ·Status: COMPLETED ·Phase: NA
-
Effects of Kalydeco on Upper Airway and Paranasal Sinus Inflammation Measured by Nasal Lavage and on Symptoms
NCT02311140 ·Status: COMPLETED
-
Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis
NCT00266474 ·Status: COMPLETED
-
A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection
NCT04966234 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways
NCT04171583 ·Status: COMPLETED
-
Cardiopulmonary Fitness in Children With Cystic Fibrosis Compared to Healthy Children
NCT06242951 ·Status: COMPLETED
-
Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of Life
NCT00977158 ·Status: WITHDRAWN
-
Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs
NCT00590330 ·Status: COMPLETED
-
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
NCT01805713 ·Status: COMPLETED
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects
NCT06339450 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.
NCT03312075 ·Status: TERMINATED
-
Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients
NCT00669760 ·Status: COMPLETED
-
Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional Study
NCT01150136 ·Status: COMPLETED
-
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
NCT00043225 ·Status: COMPLETED
-
Airway Microbiome of Cystic Fibrosis Patients
NCT06057558 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function
NCT04138589 ·Status: COMPLETED
-
Microbial Biomarkers of EArly Pseudomonas Aeruginosa Colonization in CHildren With Cystic Fibrosis
NCT03947957 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis
NCT02003079 ·Status: COMPLETED
-
Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine
NCT04137133 ·Status: RECRUITING ·Phase: NA
-
Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
NCT01429259 ·Status: COMPLETED ·Phase: PHASE4
-
Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis
NCT04024423 ·Status: COMPLETED
-
Inflammatory and Microbiologic Markers in Sputum: Comparing Cystic Fibrosis With Primary Ciliary Dyskinesia
NCT01155115 ·Status: COMPLETED ·Phase: NA
-
Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population
NCT07303621 ·Status: RECRUITING